Nanoscale Biomarkers for Cancer Genomics and Protemics

Abstract

We are facing tremendous opportunities and challenges in combining emerging nanotechnology with genomic signal processing techniques in developing faster, smaller, yet more accurate and sensitive biomedical devices in cancer genomics and proteomics. The goal is to better understand the cancer mechanisms at the cellular and even subcellular levels. Nanotechnology has been applied to study the dynamic processes of individual cells, such as cell cycle and cell migration, which can provide rich spatial and temporal phenotype information. In this article, we present the concept of nanoscale biomarkers for cancer genomics and proteomics